Are the Newer Carbapenems of Any Value against Tuberculosis

Our aim was to assess whether newer carbapenems with a better administration profile than meropenem (ertapenem, faropenem and tebipenem) were more effective against <i>Mycobacterium tuberculosis</i> including M/XDRTB and determine if there was a synergistic/antagonistic effect with amoxi...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Ximena Gonzalo (Dahkki), Francis Drobniewski (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: MDPI AG, 2022-08-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

Connect to this object online.

3rd Floor Main Library

oažžasuvvan: 3rd Floor Main Library
Hildobáiki: A1234.567
Njađus 1 Oažžumis